No legal services. No Monegasque, French, Luxembourg, or US entity formation. No SFO or MFO structure design. No foundation, trust, or SPV setup. No Monegasque residency advice. No EB-5, E-2, L-1, or O-1 visa work. No US tax structuring, FATCA analysis, CRS analysis, or double-tax-treaty review. No US banking introductions. No fiduciary services. No regulatory licensing. No clinical strategy, IND filing, or US reimbursement-pathway design where biotech or medtech work is in scope. No IP filing. No contract drafting.
These belong with Monegasque counsel, French and Swiss counsel where adjacent structures are involved, US counsel on the American side, and clinical and regulatory specialists where applicable. The firm works inside the parameters they set. When a marketing decision carries legal, tax, fiduciary, residency, clinical, or regulatory implications, the firm flags it and defers before execution.